Pictet Asset Management (Switzerland)’s Bio-Techne TECH Stock Holding History

Pictet Asset Management (Switzerland)’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q2	$25.6M	Buy	312,999 +7,326	+2%	+$589K	0.03%	408
2023 Q1	$22.7M	Buy	305,673 +32,090	+12%	+$2.47M	0.03%	435
2022 Q4	$22.7M	Buy	273,583 +74,099	+37%	+$5.88M	0.03%	419
2022 Q3	$14.2M	Buy	199,484 +3,096	+2%	+$268K	0.02%	499
2022 Q2	$17M	Sell	196,388 -2,900	-1%	-$272K	0.02%	491
2022 Q1	$21.6M	Buy	199,288 +126,748	+175%	+$13.1M	0.02%	483
2021 Q4	$9.38M	Sell	72,540 -824	-1%	-$101K	0.01%	687
2021 Q3	$8.89M	Buy	+73,364	New	+$8.93M	0.01%	697

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

DDC

DF Dent & Co Baltimore, Maryland $5.22B AUM 2.07% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Pictet Asset Management (Switzerland)'s TECH Position: Q2 2023 in Review

Pictet Asset Management (Switzerland) increased its Bio-Techne (TECH) stake by 2.4% in Q2 2023, buying an estimated $589K and bringing the position to 312,999 shares worth $25.6M. The position accounts for 0.03% of the portfolio, ranked #408.

Pictet Asset Management (Switzerland) first reported a position in TECH in Q3 2021 and has held it in 8 quarters since. 529 funds tracked by Wall St. Rank hold TECH as of Q2 2023.

Pictet Asset Management (Switzerland) held 312,999 shares of Bio-Techne worth $25.6M as of Q2 2023.
Pictet Asset Management (Switzerland) bought 7,326 Bio-Techne shares in Q2 2023, an estimated $589K.
Bio-Techne made up 0.03% of Pictet Asset Management (Switzerland)'s portfolio in Q2 2023, its #408 holding.
Pictet Asset Management (Switzerland) first reported a position in Bio-Techne in Q3 2021 and has held it in 8 quarters since.
529 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2023.

Based on Pictet Asset Management (Switzerland)'s 13F filing for Q2 2023, filed 10 Aug 2023.